medline.ch Onkologie Urologische Tumoren

	Oxidative stress as a catalyst in prostate cancer progression: unraveling molecular mechanisms and exploring therapeutic interventions. Discov Oncol Song Y, Hou Z, Zhu L, Chen Y, Li J. PMID: 40178629 [PubMed]
	"I've got plenty of energy when I'm doing something I want to do": applying self-determination theory to exercise motivation in people with prostate cancer. Support Care Cancer Naismith H, Dhillon HM, Hunter J, Bultijnck R, Kneebone A, Hruby G, Eade T, Parker L, Campbell R, Yee J. PMID: 40178616 [PubMed - in process]
	RNF112 Facilitates Ubiquitin-Mediated Degradation of c-Myc, Suppressing Proliferation, Migration and Lipid Synthesis in Bladder Cancer. Adv Sci (Weinh) Xiong K, Chen S, Xu H, Tu S, Weng H, Wang Y, Li M, Yu J, Qian K, Ju L, Zhang Y, Xiao Y, Wang X, Wang G. PMID: 40178292 [PubMed - as supplied by publisher]
	Preoperative CT radiomics-based model for predicting Ki-67 expression in clear cell renal cell carcinoma patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban Yang Z, He H, Zhang Y, Wang J, Zhang W, Zhou F. PMID: 40177755 [PubMed - in process]
	The safety and efficacy of BCG combined with mitomycin C compared with BCG monotherapy in patients with non-muscle-invasive bladder cancer: A systematic review and meta-analysis. Open Med (Wars) Liu J, Zhou W, Zhang W, Chang C, Zhang P, Fu G. PMID: 40177654 [PubMed]
	Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies. Explor Target Antitumor Ther Di Spirito A, Balkhi S, Vivona V, Mortara L. PMID: 40177538 [PubMed]
	Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation. BMJ Oncol Dodkins J, Cook A, Mayne E, Parry M, Nossiter J, Payne H, Cowling TE, Tree A, Aggarwal A, Clarke N, van der Meulen J. PMID: 40177173 [PubMed]
	Performance of PCA3 and TMPRSS2:ERG Within the Prostate Cancer Prevention Trial Risk Calculator Version 2 in a Lithuanian Cohort. Res Rep Urol Kemesiene J, Nicolau C, Cholstauskas G, Zviniene K, Lopeta M, Veneviciute S, Asmenaviciute I, Tamosauskaite K, Pikuniene I, Jievaltas M. PMID: 40176971 [PubMed]
	Response to Comment on: Comparative outcomes of partial versus total penectomy for penile carcinoma: a retrospective cohort study on demographics and postoperative complications. Int J Impot Res Kalidoss S, Velasquez D, Liu A, Raheem O. PMID: 40175614 [PubMed - as supplied by publisher]
	Effectiveness of the Continuous Care Model on Quality of Life, Sexual Satisfaction and Function in Bladder Cancer Patients Undergoing Tumor Resection Surgery: A Randomized Control Trial. Clin Genitourin Cancer Rezaeeniya F, Hasandoost F, Abedi AR, Amanollahi A, Moosavi S. PMID: 40175213 [PubMed - as supplied by publisher]
	A mendelian randomization study on the association between type 2 diabetes and the risk of bladder cancer. Discov Oncol He Y, Chen Y, Gao C. PMID: 40172743 [PubMed]
	External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancer. Eur J Nucl Med Mol Imaging Van Bergen TD, Braat AJAT, Hermsen R, Heetman JG, Wever L, Lavalaye J, Vinken M, Bahler CD, Tann M, Kesch C, Telli T, Chiu PK, Wu KK, Zattoni F, Evangelista L, Ceci F, Miszczyk M, Rajwa P, Barletta F, Gandaglia G, Van Basten JA, Scheltema MJ, Van Melick HHE, Van den Bergh RCN, Van den Berg CAT, Marra G, Soeterik TFW, EAU-YAU Prostate Cancer Working Party. PMID: 40172694 [PubMed - as supplied by publisher]
	Construction of a novel prognostic model based on lncRNAs-related to DNA damage repair for predicting the prognosis of clear cell renal cell carcinoma. Ann Med Chen P, Li J, Tian R. PMID: 40172678 [PubMed - indexed for MEDLINE]
	A prognostic model for survival of patients with metastatic upper tract urothelial carcinoma with first-line systemic therapy. World J Urol Li S, Wei J, Xu H, Wu X, Li J, Zhou L, Yan X, Tang B, Si L, Cui C, Chi Z, Guo J, Sheng X. PMID: 40172675 [PubMed - indexed for MEDLINE]
	Predicting clinically significant prostate cancer in PI-RADS 3 lesions using MRI-based radiomics: a literature review of methodological variations and performance. Abdom Radiol (NY) Serrano A, Louviere C, Singh A, Ozdemir S, Hernandez M, Balaji KC, Gopireddy DR, Gumus KZ. PMID: 40172658 [PubMed - as supplied by publisher]
	[Bispecific antibodies in prostate cancer therapy]. Urologie Jung S, Heitmann J, Pflügler M, Jung G, Rausch S, Salih H. PMID: 40172632 [PubMed - as supplied by publisher]
	Prognostic value of pathological sensitivity for high-risk, localized prostate cancer receiving neoadjuvant hormonal therapy combined with radical prostatectomy. Ann Med Shi K, Chen S, Wang X, Wang W, Zhu Y, Han B, Wang Y, Shi B. PMID: 40172626 [PubMed - indexed for MEDLINE]
	Robot-assisted partial nephrectomy and robot-assisted radical prostatectomy using the Chinese surgical systems KangDuo-SR-2000 and EDGE MP1000 versus the Da Vinci Xi system: a prospective, single-center, non-randomized clinical trial. World J Urol Guo P, Wang H, Wang Z, Xu T, Li J, Xu Y, Ding D, Li C, Teng L, Chen H, Chen Y, Qiao Z, Cao M, Du C, Li H, Wang Z, Xu W. PMID: 40172599 [PubMed - indexed for MEDLINE]
	Effect of androgen deprivation therapy after radical prostatectomy on urinary symptoms. Urologia Kawaguchi S, Shigehara K, Kadono Y, Kato Y, Kano H, Makino T, Naito R, Iwamoto H, Yaegashi H, Nohara T, Izumi K, Mizokami A. PMID: 40172008 [PubMed - indexed for MEDLINE]
	Usefulness of multiparametric MRI for local staging of bladder cancer. Urologia Paudyal P, Mete U, Gorsi U, Kumar S, Kakkar N. PMID: 40172007 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 166149

Seite 1 von 8308

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung